<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>108(5)</volume><submitter>Tanariyakul M</submitter><pubmed_abstract>The clinical impact of Strongyloides stercoralis hyperinfection secondary to immunosuppressive therapy for coronavirus disease 2019 (COVID-19) has been an emerging topic of interest, although characteristics of Strongyloides infection in COVID-19 patients are not yet well characterized. This study summarizes the existing evidence of Strongyloides infection in COVID-19 patients and recommends future areas of research. According to the PRISMA Extension for Scoping Reviews, we performed a search on MEDLINE and EMBASE for articles with keywords including "Strongyloides," "Strongyloidiasis," and "COVID-19" from the inception of these databases to June 5, 2022. A total of 104 articles were found. After excluding duplication and thorough reviews, 11 articles, including two observational studies, </pubmed_abstract><journal>The American journal of tropical medicine and hygiene</journal><pagination>901-905</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10160902</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical Characteristics of Strongyloidiasis during the COVID-19 Pandemic: Systematic Scoping Review.</pubmed_title><pmcid>PMC10160902</pmcid><pubmed_authors>Nishimura Y</pubmed_authors><pubmed_authors>Chang B</pubmed_authors><pubmed_authors>Su M</pubmed_authors><pubmed_authors>Tanariyakul M</pubmed_authors><pubmed_authors>Keitoku K</pubmed_authors><pubmed_authors>Hagiya H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical Characteristics of Strongyloidiasis during the COVID-19 Pandemic: Systematic Scoping Review.</name><description>The clinical impact of Strongyloides stercoralis hyperinfection secondary to immunosuppressive therapy for coronavirus disease 2019 (COVID-19) has been an emerging topic of interest, although characteristics of Strongyloides infection in COVID-19 patients are not yet well characterized. This study summarizes the existing evidence of Strongyloides infection in COVID-19 patients and recommends future areas of research. According to the PRISMA Extension for Scoping Reviews, we performed a search on MEDLINE and EMBASE for articles with keywords including "Strongyloides," "Strongyloidiasis," and "COVID-19" from the inception of these databases to June 5, 2022. A total of 104 articles were found. After excluding duplication and thorough reviews, 11 articles, including two observational studies, </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-22T05:11:32.51Z</modification><creation>2025-04-05T21:17:33.366Z</creation></dates><accession>S-EPMC10160902</accession><cross_references><pubmed>36940666</pubmed><doi>10.4269/ajtmh.22-0671</doi></cross_references></HashMap>